From: Role of fused PET/CT compared to the standard contrast-enhanced CT in the follow-up assessment of the treated gastric malignancy
Histopathology type
No. of patients
% of patients
Adenocarcinoma
50 patients
73.5%
Lymphoma
16 patients
23.5%
Carcinoid
2 patients
3%